Viemed Healthcare, INC Form 4 insider transactions

Viemed Healthcare's Chief Medical Officer, William Frazier, reported transactions involving the acquisition and disposition of common shares and stock options.

Viemed Healthcare Director Timothy Smokoff reported a series of stock sales on June 24, 2026, totaling 15,364 common shares.

Viemed Healthcare President Michael Moore sold 136,802 common shares indirectly through Moore Faster LLC in mid-March 2026.

Viemed Healthcare CEO Casey Hoyt reported the vesting of restricted stock units and phantom share units, leading to an increase in direct beneficial ownership after tax withholdings and cash settlements.

Viemed Healthcare's VP of Sales, Jerome Cambre, reported the vesting and settlement of restricted stock units and phantom shares.

Viemed Healthcare President Michael Moore reported the vesting of restricted stock and phantom share units, alongside tax-related share dispositions.

Jeremy Trahan, General Counsel of Viemed Healthcare, Inc., reported the vesting of restricted stock units and phantom shares, alongside related tax and cash settlement dispositions.

Viemed Healthcare's Chief Medical Officer, William Frazier, acquired common shares through RSU and phantom share vesting, simultaneously selling a portion to cover tax obligations.

Viemed Healthcare's CFO, Trae Fitzgerald, reported the scheduled vesting of restricted stock and phantom share units, alongside tax-related share dispositions.

VIEMED Healthcare's COO, William Todd Zehnder, reported the vesting and settlement of restricted stock units and phantom shares, alongside tax-related dispositions.

Viemed Healthcare's Chief Medical Officer, William Frazier, reported the scheduled vesting and settlement of executive compensation awards.

VIEMED Healthcare President Michael Moore reported the vesting and settlement of restricted stock units and phantom share units, along with related tax withholdings.

VIEMED HEALTHCARE CEO Casey Hoyt reported the vesting and exercise of restricted stock units and phantom share units, alongside tax-related share withholdings.

Viemed Healthcare's COO, William Todd Zehnder, reported the vesting and exercise of restricted stock units and phantom share units, alongside tax-related share dispositions.

Viemed Healthcare's CFO, Trae Fitzgerald, reported the vesting of restricted stock units and phantom share units, alongside related tax withholdings.

VIEMED Healthcare's VP of Sales, Jerome Cambre, reported the vesting of restricted stock units and phantom share units, alongside related share dispositions for tax obligations.

Viemed Healthcare's General Counsel, Jeremy Trahan, reported the vesting and settlement of restricted stock units and phantom shares, alongside tax-related share dispositions.

Viemed Healthcare CEO Casey Hoyt reported the vesting of restricted stock and phantom share units, along with new equity grants, and tax-related share dispositions.

Viemed Healthcare's Chief Medical Officer, William Frazier, received awards of 11,690 Restricted Stock Units and 2,922 Phantom Share Units.

Viemed Healthcare's President, Michael Moore, reported significant equity transactions including RSU and phantom share vesting, tax-related dispositions, and new equity grants.

Viemed Healthcare's Chief Operating Officer, William Todd Zehnder, reported routine vesting of restricted stock units and phantom share units, along with new equity grants.

Viemed Healthcare's VP of Sales, Jerome Cambre, reported the vesting and grant of equity awards, including restricted stock units and phantom share units.

Viemed Healthcare's CFO, Trae Fitzgerald, reported recent equity compensation transactions including RSU vesting, tax-related share dispositions, and new RSU and Phantom Share Unit grants.

Viemed Healthcare's General Counsel, Jeremy Trahan, reported the vesting of restricted stock units and phantom shares, along with new equity awards.

Viemed Healthcare's General Counsel, Jeremy Trahan, reported the vesting and settlement of phantom share units and restricted stock units, alongside related share dispositions for cash and tax obligations.

Viemed Healthcare Director Nitin Kaushal exercised 15,732 restricted stock units and received a new grant of 18,786 units.

Viemed Healthcare Director Timothy Smokoff reported the vesting of restricted stock units and new equity grants, increasing his direct common share holdings.

Viemed Healthcare Director Randy E. Dobbs reported the exercise of Restricted Stock Units and the grant of new equity awards.

VieMed Healthcare director Sabrina Heltz reported the vesting and acquisition of common shares, along with new grants of restricted stock units and phantom shares.

Viemed Healthcare's Vice President of Sales, Jerome Cambre, sold 4,880 common shares for approximately $35,770.